Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of clinical studies

Clinical Studies where

Name	Description	NCT Number	Trial Recruitment Size	Clinical Trial Start Date	Study Completion Date	Clinical Trial Study Type	Interventional Trial Phase
‌ A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy and Immunocompromised Adults	Clinical trial NCT04380701 is a trial investigating the safety and effects of four BNT162 vaccines against COVID-2019 in healthy adults.	NCT04380701	200	April 23, 2020	August 1, 2020	Interventional	Phase 1Phase 2
‌ Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals	The trial (NCT04368728) is an intervention trial that tests the efficacy of candidate vaccines against SARS-CoV-2, the novel coronavirus that causes COVID-19 disease.	NCT04368728	43,998	April 29, 2020	December 11, 2022	Interventional	Phase 2Phase 3
‌ A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19	This trial (NCT04470427) is an interventional trial testing the efficacy of vaccine candidates for SARS-CoV-2, the novel coronavirus which causes COVID-19 disease.	NCT04470427	30,000	July 27, 2020	October 27, 2022	Interventional	Phase 3
‌ Comparing the Incidence of Parastomal Hernia After Mesenteric Molding Suturing and Non-molding Suturing in Colostomy Surgery		NCT06674187	234	November 1, 2024	January 1, 2026	Interventional	Not Applicable
‌ Postoperative Dexamethasone Injected Into Masseter Muscle and Pterygomandibular Space After Mandibular Third Molar Surgery; Comparison of Effects on Pain, Edema and Trismus		NCT06604286	20	April 28, 2023	April 27, 2024	Interventional	Phase 4
‌ Perfectionism and Daily Coping and Emotion Regulation Processes: a Trial of Explanatory Feedback Interventions		NCT06625151	200	2024	2026	Interventional	Not Applicable
‌ Glibenclamide (Dose to be Titrated From Starting Dose of 5mg om) Plus Rosiglitazone 4mg om (Increased to 8mg om After 6 Months) and vs Glibenclamide (Dose to be Titrated With Starting Dose of 5mg om) Plus Placebo, Administered to Patients With Type 2 Diabetes Mellitus		NCT01045590	100	2003	2006	Interventional	Phase 4
‌ Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)		NCT06354179	162	July 1, 2024	July 1, 2027	Interventional	Phase 4
‌ Women's Walking Program		NCT01700894	288	2010	2012	Interventional	Not Applicable
‌ NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)		NCT06239272	139	2024	2037	Interventional	Phase 1Phase 2
‌ Social Prescribing to Improve Adherence and Outcomes in Women With Heart Failure		NCT06628973	200	January 1, 2025	December 31, 2028	Interventional	Not Applicable
‌ Development of the Wearable Arm Volume Measurement Device and Mobile Application		NCT06507033	14	2024	2027	Interventional	Not Applicable
‌ Randomized Clinical Trial Investigating Efficacy of EFT (Emotional Freedom Technique) for Food Cravings		NCT00668993	60	2008	2009	Interventional	Not Applicable
‌ Procalcitonin To Reduce Antibiotics in Chronic Obstructive Lung Disease (ProToCOLD)		NCT01950936	120	2012	2013	Interventional	Phase 2Phase 3
‌ A Study of the Effects of a Novel Ovarian Stimulation Regimen on Embryo Aneuploidy Rates in In Vitro Fertilization (IVF)		NCT00866008	34	2008	2011	Interventional	Phase 4
‌ A Study to Find a Suitable Dose of ASP2802 in People With CD20-positive B-cell Lymphomas		NCT06248086	21	February 29, 2024	May 31, 2031	Interventional	Phase 1
‌ From Court to the Community: Improving Access to Evidence-Based Treatment for Underserved Justice-Involved Youth At-Risk for Suicide		NCT06227169	45	April 15, 2023	February 28, 2027	Observational
‌ Effects of the Anti-inflammatory Flavonoid Luteolin on Behavior in Children With Autism Spectrum Disorders		NCT01847521	50	2011	2013	Interventional	Phase 2
‌ The Outcome Effect of Shoe Lift for Individuals With Low Back Pain and Pronated Foot Due to Anatomical Leg Length Discrepancy		NCT01187693	60	2010	2011	Interventional	Not Applicable
‌ Randomized Controlled Trial (RCT) in Children With Severe Pneumonia		NCT00455468	368	2005	2009	Interventional	Not Applicable
‌ Family Support Protocol for Adolescent Internalizing Disorders		NCT06413979	60	April 1, 2025	December 31, 2026	Interventional	Not Applicable
‌ EARNEST Rifabutin Pharmacokinetics (PK) Substudy		NCT01663168	140	2011	2014	Interventional	Phase 2
‌ Super High-Flux - High Volume Dialysis in Sepsis-Induced Acute Renal Failure		NCT00333593	10	2006	2006	Interventional	Phase 1Phase 2

...

Results per page:

425,242 results

0 selected

425,242 results

0 selected